SINGAPORE] Alcon, a Swiss-American pharmaceutical and medical device company specialising in eye care products, opened its ...

Alcon ALC has unveiled its latest innovations and expansive suite of vision care products at the SECO 2023 International Meeting in Atlanta, GA. The company announced that it debuted TOTAL30 ...

It will support the global production of the firm’s flagship contact lenses. Read more at straitstimes.com. Read more at ...

Alcon has a suite of products for dry eye, eye allergy, eye vitamins/supplements, and contact lens solutions, and it is the leading player in the ocular health space.

In this Healio Video Perspective from SECO 2025, Kristen Brotherson, general manager of U.S. vision care at Alcon, outlined the company’s latest eye care innovations being premiered at the ...

Alcon has a suite of products for dry eye, eye allergy, eye vitamins/supplements, and contact lens solutions, and it is the leading player in the ocular health space.

Alcon helps people see brilliantly. As the global leader in eye care with a heritage spanning over 75 years, we offer the broadest portfolio of products to enhance sight and improve people’s ...

Alcon recalls Systane Ultra PF Eye Drops (Lot 10101) ... In a statement, the company assured that it is working diligently to ensure all affected products are removed from circulation and replaced.

Alcon acquired a majority interest in Aurion Biotech, a clinical-stage company developing advanced cell therapies to treat eye diseases. Terms of the deal weren't disclosed. Aurion will operate as ...

As Alcon is developing those new products, its R&D Department listens to the voices of eye experts around the world, with particular attention to the needs of Chinese patients.

Alcon to Buy Lensar in Deal Worth Up to $430M. Published: March 24, 2025 at 8:21 a.m. ET. ... and an additional $2.75 per share based on certain milestones for Lensar's products in 2026 and 2027.

Alcon, which produces contact lenses, eye drops and other related products, said its sales rose 6% in constant currency to $2.4 billion in the final quarter of 2024, matching analysts' estimates ...